Supplementary material Supplementary Material 1: Statistical methods Supplementary Material 2 - Table 1: Data stratified according to bimekizumab dose regimen Supplementary Material 3 - Table 2: Dat

Mendeley Data20

Predicted relapse rates for hypothetical regimens of 4, 5, and 6 months duration, according to the rate of sputum culture positivity at 2 months.

结核病治疗优化

临床疗效预测

The confidence interval (CI) indicates uncertainty regarding the population relapse rate. The prediction interval (PI) indicates uncertainty regarding the predicted relapse rate in a future study with

Figshare2015-12-02 更新40

Baseline characteristics and laboratory findings of patients starting their first TNF-α inhibitor according to whether they subsequently switched or not.

风湿免疫治疗

生物制剂疗效评估

TNF, tumor necrosis factor; BMI, body mass index; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; AST, aspartate aminotransfer

NIAID Data Ecosystem30

Predictors of outcome in patients treated with Rituximab.

资源简介：

相关数据集